|
Gender (n, %)
| |
|
Male
|
115 (89.1)
|
|
Female
|
14 (10.9)
|
|
Age (years)
|
60.9 ± 8.8
|
|
Marital status (n, %)
| |
|
Married
|
106 (82.2)
|
|
Single/Divorced/Windowed/Separated
|
23 (17.8)
|
|
Highest education level (n, %)
| |
|
No formal education
|
8 (6.2)
|
|
Primary education
|
26 (20.2)
|
|
Secondary education
|
60 (46.5)
|
|
Tertiary education and above
|
35 (27.1)
|
|
Employment status (n, %)
| |
|
Full-time/Part-time working
|
87 (67.4)
|
|
Retired/Not working
|
42 (32.6)
|
|
Monthly household income (SGD)
| |
|
≤ 1000
|
23 (17.8)
|
|
1001–3000
|
46 (35.7)
|
|
3001–5000
|
30 (23.3)
|
|
> 5000
|
29 (22.5)
|
|
Type of housing (n, %)
| |
|
Government house/HDB flat
|
122 (94.6)
|
|
Private house
|
7 (5.4)
|
|
Clinical characteristics
| |
|
Length of CHD diagnosis (months)
|
36.0 (1.0–360.0)
|
|
CHD family history (n, %)
|
55 (42.6)
|
|
Diabetes
|
57 (44.2)
|
|
High cholesterol
|
129 (100)
|
|
Hypertension
|
108 (83.7)
|
|
Ex-smoker
|
74 (57.4)
|
|
Current smoker
|
26 (20.2)
|
|
Alcohol
|
30 (23.3)
|
|
PTCA/Stent therapy
|
89 (69.0)
|
|
CABG therapy
|
31 (24.0)
|
|
Medication
| |
|
Antiplatelets
|
123 (95.3)
|
|
Nitrates
|
34 (26.4)
|
|
Beta-blockers
|
89 (69.0)
|
|
ACE inhibitors
|
58 (45.0)
|
|
Calcium antagonists
|
28 (21.7)
|
|
Lipid-lowering drugs
|
122 (94.6)
|
|
Others
|
120 (93.0)
|
|
Physiological data
| |
|
Triglycerides (mmol/L)
|
1.38 (0.52–16.01)
|
|
Total cholesterol (mmol/L)
|
4.06 (2.45–10.52)
|
|
Low-density lipoprotein (mmol/L)
|
2.18 (0.53–6.07)
|
|
High-density lipoprotein (mmol/L)
|
1.11 ± 0.24
|
|
Fasting blood glucose (mmol/L)
|
5.75 (4.00–22.50)
|
|
Systolic blood pressure (mmHg)
|
135.90 ± 23.51
|
|
Diastolic blood pressure (mmHg)
|
74.22 ± 11.41
|
|
BMI
|
26.70 ± 5.04
|
